-
Guidelines for Substitution of a Different Formulation for a Prescribed Drug
-
Dispensing the Appropriate Capsule Combination for the Daily Dose of Temozolomide
-
Criteria for an Accurate Prescription of a Nebulized Bronchodilator
-
Dispensing the Appropriate Tablet Combination for the Daily Dose of Xeloda (Capecitabine)
-
Dispensing the Appropriate Number of Capsules of Succimer for Chelating Heavy Metals
-
Determining the Appropriate Dose of Sevelamer Hydrochloride to Control Serum Inorganic Phosphorus Levels in Patients with End Stage Renal Failure
-
Dispensing Sufficient Medication to Fill a Prescription
-
Amount of Cream or Ointment to Dispense for Topical Skin Application
-
Criteria for a Valid Prescription
-
Determining the Price to Charge for a Prescription
-
Calculation of the Weight of a Drug Compound to Dispense to Deliver a Target Dose of the Active Drug Moiety
-
Food and Drug Administration (FDA) Rules for Importation of an Unapproved Drug
-
Converting a Patient from Intravenous to Oral Drug Administration
-
Dispensing Sufficient Oseltamivir to Treat a Patient for Influenza
-
Reducing the Risk of Forged or Altered Prescriptions
-
Dispensing Sufficient Voriconazole (Vfend) for Intravenous Infusion
-
Dosing Nelfinavir mesylate (Viracept) for Oral Therapy in a Child
-
Predictors of Miller et al Identifying a Patient with a Chronic Disease Who Comes to the Emergency Department for a Drug Refill
-
When to Investigate a Generic Drug for Therapeutic Effectiveness
-
Recommendations of the US Food and Drug Administration (FDA) on Selecting a Website from Which to Purchase a Prescription Medication Online
-
Hazards of Buying Medications On-Line from an Unscrupulous Website
-
Dispensing Sufficient Ulesfia Lotion (5% Benzyl Alcohol) for the Treatment of Head Lice
-
Fingertip Unit (FTU) and Dosing of a Topical Cream
-
Dosing a Saturated Solution of Potassium Iodide (SSKI)
-
Patient Assessment and Instruction in the Use of an Inhaler
-
Score of Ruscin and Semla for Evaluating a Patient's Ability to Perform Tasks Associated with Taking Tablets or Pills
-
Dosage Forms Subscore of the Medication Regimen Complexity Index (MRCI)
-
Dosing Frequency Subscore of the Medication Regimen Complexity Index (MRCI)
-
Subscore for Additional Directions of the Medication Regimen Complexity Index (MRCI)
-
Medication Regimen Complexity Index (MRCI)
-
Impact of Numeracy on a Patient’s Ability to Take a Medication
-
Identification of High Risk Medications
-
Schedules for Controlled Substances
-
Scale of Nutt et al for Assessing the Harm of a Drug's Misuse Potential
-
Principles for Off-Label Use of a Medication
-
Handling a Drug Shortage
-
Information That Should Be Included in the Label Placed on a Sterile Product Prepared in a Pharmacy
-
Reasons for a Drug Shortage
-
Handling Glacial Acetic or Other Strong Acids
-
Medication Appropriateness Index of Hanlon et al
-
General Rules for Treatment of a Chronic Condition from the International Consensus Guidelines for the Therapy of Idiopathic Pulmonary Fibrosis
-
Criteria for Unlabeled Use of a Medication (Off-Label Drug Use)
-
The Geriatric Medication Evaluation Algorithm of Newton et al.
-
Troubleshooting the Failure of a Patient to Respond to a Medication
-
Summated Score of Samsa et al for the Medication Appropriateness Index of Hanlon et al
-
Clinical Utility Score of Kain
-
Comparison of Antiepileptic Drugs Using the Monostars Score of Brodie
-
NO TEARS Tool for Medication Review
-
Total Cumulative Drug Exposure Over Time
-
Reasons Why an Antibiotic May Be Prescribed When Unnecessary
-
1997 Beers Diagnosis Independent Criteria to Identify Potentially Inappropriate Drug Use In an Elderly Patient
-
Identifying Unnecessary Antibiotic Usage Near the End of Life
-
CNS Penetration Effectiveness (CPE) Score for an Antiretroviral Drug Regimen
-
Problems Listed by Rollason and Vogt Associated with Polypharmacy
-
Pseudopolypharmacy
-
Predictors of Nyhuis et al for Switching an Antipsychotic Medication in a Patient with Schizophrenia
-
Criteria of Rapoport et al for Evaluating Triptan Therapy of Migraine
-
Therapeutic Duplication
-
Risk Factors for a Serious Complication in a Pediatric Patient Receiving of a Cough and Cold Remedy
-
Risk Factors of Harugeri et al for High-Level Polypharmacy in an Elderly Hospital Patient
-
Listing of Drugs with a Narrow Therapeutic Index from the North Carolina Board of Pharmacy
-
Potentially High Risk Medications
-
Drug Burden Index (DBI) of Hilmer et al (Total Drug Burden, TDB)
-
Drug Holiday (On/Off Treatment, Strategic Treatment Interruption)
-
A Checklist for Informing the Patient About a New Medication
-
The MedTake Test for Determining a Patient's Familiarity with Medications
-
A Patient Questionnaire Before Using Imitrex Nasal Spray for Migraine Headaches
-
Risk Factors of Sorensen et al for a Poor Health Outcome Based On How a Patient Manages Medications at Home
-
Dosing a Drug With an Additional Side Chain (Fosphenytoin and Phenytoin Equivalents)
-
Effects of Hydration on Drug Dosage
-
Dosing a Drug Formulated as a Salt
-
Equivalent Anti-Inflammatory Oral or Intravenous Corticosteroid Dose
-
Equivalent Narcotic (Equianalgesic) Drug Doses
-
Converting a Patient with ADHD to Extended Release Methylphenidate
-
Converting a Patient from Depakote to the Extended Release (ER) Formulation
-
FDA Criteria for Therapeutic Equivalence Between Two Drug Preparations
-
Converting a Patient Taking Intravenous Immune Globulin to Subcutaneous Immune Globulin (SCIG, Vivaglobin)
-
Equivalent Doses of Theophylline and Related Methylxanthines
-
Total Levodopa Equivalents (Levodopa Equivalent Daily Dose, LEDD)
-
Dose Equivalents for Dopamine Agonists As Reported by Hobson et al.
-
Equivalent Doses of Loop Diuretics (Furosemide Equivalents)
-
FDA Therapeutic Equivalence Evaluation Codes
-
Indications for Using Parenteral Morphine for Control of Severe Pain
-
Method of Mercadante et al for Titrating Intravenous Morphine in a Patient with Severe Cancer Pain with Immediate Conversion to Oral Dosing
-
Method of Nelson et al for Administration of Parenteral Morphine for a Patient with Severe Cancer Pain
-
Method of Indelicato and Portenoy for Opioid Rotation in a Patient with Refractory Cancer Pain
-
Conversion of a Patient to Oral Oxycontin According to the Physicians' Desk Reference (PDR)
-
Management of Acute Pain in a Substance Abuser
-
Dosing Tylenol (Acetaminophen) in Children
-
Calculating the Aspirin Conversion Factor (ACF) for a Salicylate
-
Calculating the Aspirin Equivalent Dose (AED) for a Salicylate
-
Increase in Fentanyl Patch Strength to Adjust for Frequent Episodes of Breakthrough Pain
-
Conversion of an Oral Morphine Dose to a Transdermal Fentanyl Patch Strength
-
Features Suggestive of Drug Seeking Behavior in a Patient
-
Risk Factors of Ives et al for Opioid Misuse in a Patient with Chronic Pain
-
Patient Agreement with the Physician for the Use of Opioid or Other Controlled Substances
-
Contraindications for the Use of a Fentanyl Transdermal Patch in a Patient with Pain
-
Factors Associated with Toxic Symptoms in a Patient Taking Extended Release Oxymorphone
-
Opioid Induced Hyperalgesia (OIH)
-
Risk Factors for Fentanyl Toxicity in a Patient Treated with a Transdermal Patch
-
Management of the Pain Associated with Diabetic Peripheral Neuropathy
-
World Health Organization (WHO) Analgesic Ladder
-
Prescription Opioid Misuse Index (POMI) of Knisely et al
-
Conversion of a Patient from Intravenous to Transdermal Fentanyl
-
Dartmouth-Hitchcock Medical Center Protocol for Dosing Fentanyl in an Adult Trauma Patient
-
Clinical Criteria of Chabal et al for Prescription Opiate Abuse in a Patient with Chronic Pain
-
Indications for the Use of Pregabalin in a Patient with Pain
-
Guidelines of Huxtable for Reducing the Risk of Herbal Use
-
Precautions for the Safe Use of Ephedrine and Related Alkaloids
-
Food and Drug Administration (FDA) Criteria for Determining If a Herb or Food Supplement Make Claims for Use in a Disease
-
Complications Associated with Fish Oil Therapy
-
WHO Guidelines for Good Agricultural and Collection Practices (GACP) for Medicinal Plants: Harvesting the Plant
-
Categories of Adverse Reactions Caused by an Herbal Remedy
-
Carcinogens in Herbal Remedies
-
Use of Valerian Root (Valeriana officinalis) and Its Withdrawal Reaction
-
Risk of Infection Following Therapy with a Naturopathic Medicine
-
FDA Categories of Drugs for Use in Pregnancy
-
Splitting Pills and Tablets
-
Maximal Use of Liquid Drug in Vials
-
Issues Affecting Outcome in Insurance Company Directed "Brown Bagging" of Chemotherapeutic Agents
-
Tablets That Should Not Be Split
-
Prevention of Prescription Errors for Controlled Substances
-
Prescription Abbreviations Associated with Dosage Errors
-
The National Coordinating Council for Medication Error Reporting and Prevention (NCCMERP) Categories for Medication Errors
-
Risk Factors for Medication Errors Identified by the American Society of Hospital Pharmacists (ASHP)
-
Risk Factors in Pharmacy Practice on Dispensing Errors
-
Reasons for Prescription Medications Being Wasted in Geriatric Outpatients
-
Risk Factors of Fialova et al for Inappropriate Medication Use in Elderly European Home Care Patients
-
Risk Factors Shi et al for a Patient to Inappropriately Use Over-the-Counter Phenazopyridine (Pyridium)
-
Types of Drug Diversion for a Controlled Substance
-
Classification of Manchikanti for Troubled Providers Who Write Prescriptions for Controlled Substances
-
Recommendations of Argo et al for Reducing Serious Medication Errors
-
Prevention of Medication Errors in the Use of Drug Look-Alikes
-
Ways In Which a Patient May Accumulate a Large Supply of a Prescription Drug
-
Recommendations of Koren and Haslam for Reducing Tenfold and Other Dose Calculation Errors
-
Risk Factors of Li et al for a Parent Giving an Inadequate Dose of an Antipyretic Agent to a Child
-
Risk Factors of Moyen et al for Medication Errors in the Intensive Care Unit (ICU)
-
Risk Factors of Valentin et al for Errors in the Administration of Parenteral Medications in the Intensive Care Unit (ICU)
-
Dose Dumping
-
Sources for Error in a Medication Dosage Equation Based on the Report of Lesar
-
Determinants of Lu and Roughead for Patient-Reported Medication Errors
-
The 7 C’s of Routledge for Safe Prescribing (and Avoiding a Titanic Error)
-
Selection of Sites for Self-Injection of Interferon-beta
-
Safety Guidelines for Patients Taking Chemotherapy Agents at Home
-
Intracavernosal Injection of Prostaglandin E1 by a Man with Erectile Dysfunction
-
Anticoagulation Using Subcutaneous Injection of Enoxaparin (Low Molecular Weight Heparin)
-
Intranasal Administration of Desmopressin Acetate
-
Subcutaneous Injection of Insulin
-
Testosterone Buccal System with Mucoadhesive (Striant)
-
General Instructions for Handling a Transdermal Therapeutic System (Drug Patch)
-
Instructions for Withdrawal of a Parenteral Dose from a Drug Vial
-
Instillation of Ofloxacin Otic Drops for an Ear Infection
-
General Instructions for a Patient Taking an Oral Bisphosphonate for Osteoporosis
-
Instructions for Application of a Vaginal Cream
-
Instructions for Administration of a Nasal Spray
-
Administration of Diazepam Rectal Gel (Diastat AcuDial) to a Patient with a Seizure Disorder
-
Handling Problems Associated with Self-Injections
-
Instructions for Handling a Potentially Toxic Medication at Home
-
Inspecting the Vial of an Injectable Preparation Prior to Withdrawing a Dose
-
Determining If a Patient is a Candidate for Patient Controlled Analgesia (PCA)
-
Patient Controlled Analgesia (PCA) By Proxy
-
Hazards of Administering a Medication in a Plastic or Styrofoam Cup
-
Use of a Miconazole Buccal Table (Oravig) for the Treatment of Oropharyngeal Candidiasia
-
Preventing Secondary Exposure Following Cutaneous Application of Testosterone Gel
-
Estimating Shelf-Life of a Drug Using the Q10 Method
-
Assessing Drug Potency After the Expiration Date
-
Methods to Detect Thawing of a Frozen Solution
-
Evaluation of a Medication for Deterioration After Exposure to the Environment
-
Problems Associated with the Freezing of Medications
-
Precautions in the Dosing and Storage of Paraldehyde
-
Deterioration of Aspirin (Acetylsalicylic Acid)
-
Deterioration of Epinephrine in an Autoinjector (EpiPen) After the Expiration Date
-
Significance of an Unexpected Odor from a Medication
-
Potential Hazards of Storing a Drug in a Container Different from the One Used to Dispense It
-
Storage of Nitroglycerin Tablets
-
Storage and Handling of Dabigatran etexilate mesylate (Pradaxa)
-
Expiration Date for a Multi-Dose Medications Vial
-
Drug Deterioration Due to Light Exposure
-
The Density Factor Method for Preparing a Medicated Suppository
-
The Occupied Volume Method for Preparing a Medicated Suppository
-
Amount of Surfactant Required to Emulsify an Oil
-
Blending Two Surfactants to Achieve a Mixture with a Specific Hydrophile-Lipophile Balance (HLB)
-
Solubility of a Drug That is the Salt of an Acid
-
Determining the pH to Dispense a Solution of a Salt of an Acidic Drug for Optimum Solubility
-
Dose Solubility Ratio
-
Descriptive Terms for Solubility of a Solute in a Solvent
-
Biopharmaceutical Classification Scheme (BCS) for Bioavailability of a Drug After Oral Administration
-
Placebo and Nocebo Effects
-
NIH Recommendations for Preparation of Parenteral Antineoplastic Agents
-
NIH Recommendations for Administration of Parenteral Antineoplastic Agents
-
Risk Level Classification of the American Society of Health-System Pharmacists (ASHP) for Pharmacy-Prepared Sterile Products
-
Monitoring a Person Who Handles or Administers Parenteral Antineoplastic Agents
-
Errors That May Occur When Compounding a Prescription
-
Indications for Preparing a Compounded Medication
-
Reasons for the FDA to Initiate an Enforcement Action Against a Compounding Pharmacy
-
Recommendations of Mattner and Gastmeier for Reducing the Risk of Bacterial Contamination of a Multiple-Dose Vial
-
Red and Yellow Flags Associated with a Compounded Product
-
Problems Caused by Child-Resistant Packaging for the Elderly
-
Problems Caused by Tamper-Resistant Packaging for the Elderly
-
Measuring the Moisture Permeability of a Container for Multiple Tablets or Capsules
-
Indications of Tenenbein for Selecting Unit Dose Packaging of a Medication
-
Testing a Tablet's Durability in a Friabilator
-
Crushing Tablets and Mixing the Powder with Food for Drug Administration to Adolescents and Adults
-
Crushing Tablets or Capsules for Drug Administration to an Infant
-
Hard Capsule Size and Volume
-
Reasons to Coat a Tablet
-
Estimating the Vapor Pressure of a Mixture of Two Liquified Gas Propellants
-
Determining the Ratio of Two Liquified Gas Propellants to Deliver a Specific Vapor Pressure for an Aerosol
-
Effect of Particle Size on the Site of Deposition in the Respiratory Tract
-
Factors Affecting the Effectiveness of Aerosol Therapy
-
Fractional Deposition of Inhaled Particles
-
Predicting a Medically Significant Reaction in Pediatric Patients Receiving an Infusion of Infliximab
-
Algorithm of Sandborn and Hanauer for Administering Infliximab to a Patient with Crohn's Disease
-
When to Suspect the Formation of Anti-Infliximab Antibodies in a Patient
-
Contraindications for the Use of Infliximab (Antibody to Tumor Necrosis Factor alpha)
-
Nomenclature for Therapeutic Antibodies
-
Immune Reconstitution Inflammatory Syndrome (IRIS) Following Discontinuation of a Tumor Necrosis Factor alpha (TNF alpha) Blocking Agent
-
Approved Indications for the Use of Etanercept (Enbrel)
-
Decision Tree of McKinnon and Avis for Selection of a Filter System for Pharmaceutical Preparation
-
Dosing and Administration of Pulmonary Surfactant (Survanta, Beractant)
-
Determining the Infusion of Epoprostenol Sodium (Flolan) for a Patient with Pulmonary Hypertension
-
Dosing Xolair (Omalizumab) in a Patient with Asthma
-
Determining the Dose of Sotalol in an Adult Patient to Control Atrial Fibrillation or Flutter
-
Determining the Dose of Sotalol in a Pediatric Patient to Control Atrial Fibrillation or Flutter
-
Maintenance Dosing of an Adult Patient with Atrial Fibrillation or Flutter Receiving Sotalol
-
Determining the Regimen of Integrilin (Eptifibatide) for a Patient with an Acute Coronary Syndrome
-
Adjusting the Dose of Eplerenone (Inspira) for a Patient with Congestive Heart Failure Based on the Serum Potassium
-
Precautions in Dosing Mitoxantrone for Patients with Multiple Sclerosis
-
Switching from Oral Rivastigmine (Exelon) to the Transdermal Patch in a Patient with Alzheimer's Disease
-
The STEPS (System for Thalidomide Education and Prescribing Safety) Program of Celgene Corporation for Thalidomide
-
The SMART (System to Manage Accutane Related Teratogenicity) Program of Roche Pharmaceuticals for Isotretinoin
-
Precautions in the Exposure to Ribavirin in a Patient of Reproductive Age
-
Determining the Amount of Sodium Chloride to Add to an Ophthalmic Solution to Make It Isotonic With Normal Tears
-
Depot Method for the Application of Topical Ophthalmologic Medication
-
Number of Drops of an Ophthalmologic Medication to Apply
-
Criteria for an Ideal Preservative in a Topical Preparation
-
Method of Application for a Cream or Ointment
-
Rule of 5 by Lipinski et al for Identifying a Drug with Poor Oral Absorption
-
Oral Absorption of an Azole for Antifungal Therapy in a Patient with Hypochlorhydria or Achlorhydria
-
Impact of Gastroparesis on Oral Drug Therapy
-
Absorption of an Oral Drug in a Patient Ingesting Activated Charcoal
-
Altered Drug Absorption Following Bariatric Surgery
-
Determining the Amount of Medication Remaining in a Metered-Dose Inhaler Canister
-
Estimating the Number of Days Left for a Metered-Dose Inhaler Canister Based on Daily Usage Pattern
-
Dosage Preparation for Continuous Bronchodilator Therapy (CBT) Delivered by a Nebulizer
-
Recommended Excess Volume for an Injectable Preparation
-
USP/NF Guidelines for Testing Injectable Preparations for Particulate Matter
-
Complications of a Drug Preparation Injected Into the Central Nervous System Secondary to a Preservative or Particulate Matter
-
Risk Factors for Buying a Counterfeit Drug
-
Hazards Associated with Use of a Counterfeit Drug
-
How to Detect a Counterfeit Drug
-
Advice to Travelers for Carrying Medications and Administration Supplies
-
Drugs That Are Absorbed Out of the Infusion Solution Onto the Infusion Set
-
Drug Refill Gap
-
Medication Possession Ratio (MPR)
-
Dosing Imodium (Loperamide HCl)
-
Dosing Methylnaltrexone (Relistor) for a Patient with Opioid-Associated Constipation
-
Guidelines for Donating Drugs During a Disaster
-
Dosing of Levothyroxine Sodium for a Pediatric Patient with Hypothyroidism
-
Dosing Zemplar (Paricalcitol) Capsules for a Patient with Secondary Hyperparathyroidism in Chronic Kidney Disease
-
Complications Associated with Long-Term Hormone Implants
-
Preparation of a Diluted Alcohol Solution (Vol/Vol) from 94.9% Alcohol
-
Properties of a Medication Suitable for Transdermal Administration
-
Ways to Enhance Absorption of a Drug After Transdermal Administration
-
Impact of Temperature on Absorption from a Transdermal Patch
-
Medication Errors Associated with Transdermal Rivastigmine (Exelon) Patches in Patients with Alzheimer's Disease
-
Possible Consequences of Drug Therapy Discontinuation
-
Reasons for Failing to Detect a Pyrogen in a Pharmaceutical Preparation
-
USP Rabbit Pyrogen Test
-
Orphan Drug
-
Problems in Disposing Pharmaceuticals By Flushing Down a Toilet or Into a Sewer
-
Hazards of Not Disposing of Outdated or Unused Drugs
-
Disposal of an Outdated or Used Fentanyl Transdermal Patch
-
Gluten in a Medication Given to a Patient with Celiac Disease
-
Taste Masking for an Oral Medication
-
Medication Intolerance Associated with Lactose Intolerance
-
Medication Factors Contributing to Diarrhea Following Administration by an Enteral Feeding Tube
-
Impact of Enteral Tube Placement on the Action of a Drug Administered by an Enteral Feeding Tube
-
Administration of Phenytoin By Enteral Feeding Tube
-
Problems Associated with Administering Drugs by an Enteral Feeding Tube
-
When Rectal Administration of a Drug Should Be Considered
-
Recommendations of Warren for Rectal Drug Administration
-
Ceiling Effect
-
Patient Assistance Programs (PAP)
-
Pharmaceutical Care Index (PCI)
-
Differential Diagnosis of Failure to Respond to an Injection of Botulinum Toxin
-
Comorbid Conditions That May Increase the Risk of Adverse Effects Following Injection of Botulinum Toxin
-
Reasons a Drug Company May Develop a New Drug When an Effective Therapy Is Present
-
Barriers to Medication Reconciliation at Hospital Admission
-
Types of Discrepancies in Medications and Instructions At Hospital Discharge
-
Risk Factors Contibuting to Discrepancies in Medications and Instructions At Hospital Discharge
-
Risk Factors of Unroe et al Associated with Discrepancies During Medication Reconciliation at Hospital Admission
-
Dose Calculation and Administration of Kcentra
-
Dosing the SSRI Citalopram Hydrobromide (Celexa)
-
Barriers to Drug Therapy in an Elderly Patient
-
Medications to Avoid in a Patient at Risk for Delirium
-
Reformulation of Opioid Analgesics to Reduce Abuse Potential (Tamper-Resistant Formulation, TRF)
-
Classification of Booth et al for Prescribing Errors in the Pediatric Intensive Care Unit
-
Recommendations of Booth et al for Preventing Prescribing Errors in the Pediatric Intensive Care Unit (Zero Tolerance Prescribing)
-
Risk Factors of Teunissen et al for Medication Administration Time Errors
-
Medication Errors Identified by Eginger et al in Highly-Active Antiretroviral Therapy (HAART) for a Hospitalized Patient
-
Reducing Medication Errors due to Look-Alike Drug Names Using Capital (“Tall Man”) Letters
-
Guidelines of Bygum et al for Self-Administration of C1 Esterase Inhibitor (C1-INH) By Intravenous Infusion
-
Benefits of Subcutaneous Self-Injection of FSH and HCG in a Male with Hypogonadotropic Hypogonadism
-
Application of Benzocaine Gel for the Temporary Relief of a Toothache
-
Cutaneous Application of Testosterone Gel for Transdermal Absorption
-
Clinical Features of an Infusion Reaction to Infliximab
-
Risk Factors of Kapetanovic et al for an Infusion Reaction to Infliximab in an Adult with Rheumatoid Arthritis
-
Improving Gastrointestinal Absorption of Griseofulvin After Oral Dosing
-
Decreased Gastrointestinal Absorption of Ciprofloxacin Associated with Calcium and Other Cations
-
Dose Adjustment in for AndroGel (Topical Testosterone Gel)
-
Methods That a Drug-Impaired Healthcare Worker May Use to Divert Drugs
-
Problems in Home-Administered Medications Identified by Walsh et al
-
Total Lifetime Dose of a Drug
-
Drug-Related Errors of Urbina et al for a Hospitalized Patient
-
Screening Tool to Alert Doctors to the Right Treatment for an Older Adult (START)
-
Prescription Errors of Al Khaja et al for Acetaminophen (Paracetamol) in Infants
-
Intravenous Administration of Acetaminophen for Post-Operative Analgesia
-
Dosing Protocol of Fusco et al for Intravenous Acetaminophen
-
Hazards of Taking an Herbal Remedy During Cancer Chemotherapy
-
Errors Associated with Reconstituting an Injected Medication
-
Drug Hoarding (Medication Hoarding)
-
High Potency Active Pharmaceutical Ingredients (HPAPI)
-
Data Collection for Oral Medication Identification
-
Age-Adjusted Dose Regimen of Laer et al for Sotatol a Pediatric Patient with Supraventricular Tachycardia
-
When to Be Cautious in Dealing with a Supplier of a Pharmaceutical Product
-
FDA Score for Adhesion of a Transdermal Patch
-
Octanol to Water Partition Ratio (Kow and log P)
-
Criteria of Braun et al for an Adequate Therapeutic Trial of an NSAID in a Patient with Ankylosing Spondylitis
-
Handling Problems in Children Who Have to Swallow Pills
-
Accuracy of an Oral Liquid Measuring Device
-
Score of Tatham et al for Grading Eye Drop Instillation Technique
-
Risk Factors for Improper Eye Drop Administration
-
Deprescribing
-
Tolerance and Tachyphylaxis
-
Herbal Interactions with Analgesic Drugs
-
Adverse Effects of Santonin (Derived from Artemisia maritima)
-
Toxicity of the Oleoresin of Aspidium (Wood Fern)
-
Potential Dosing Errors When Switching Between Drug Formulations
-
Problems Associated with the Home Medicine Cabinet
-
Complications of Tetracycline Degradation Products
-
Criteria of McLeod et al for Inappropriate Prescribing in an Elderly Patient: Basic Principles
-
Criteria of McLeod et al for Inappropriate Prescribing in an Elderly Patient: Drugs for Cardiovascular Disease
-
Criteria of McLeod et al for Inappropriate Prescribing in an Elderly Patient: Analgesic Drugs
-
Criteria of McLeod et al for Inappropriate Prescribing in an Elderly Patient: Psychotropic Drugs
-
Criteria of McLeod et al for Inappropriate Prescribing in an Elderly Patient: Miscellaneous Drugs
-
Screening Tool of Older Person's (STOPP) for Potentially Inappropriate Prescriptions: Psychotropic and CNS Drugs
-
Screening Tool of Older Person's (STOPP) for Potentially Inappropriate Prescriptions: Gastrointestinal and Genitourinary Disorders
-
Screening Tool of Older Person's (STOPP) for Potentially Inappropriate Prescriptions: Respiratory and Endocrine Disorders
-
Screening Tool of Older Person's (STOPP) for Potentially Inappropriate Prescriptions: Musculoskeletal and Pain Disorders
-
Screening Tool of Older Person's (STOPP) for Potentially Inappropriate Prescriptions: Cardiovascular Disorders
-
Screening Tool of Older Person's (STOPP) for Potentially Inappropriate Prescriptions: Drugs That Increase the Risk for Falls
-
Screening Tool of Older Person's (STOPP) for Potentially Inappropriate Prescriptions: General Principles
-
Double and Pseudo-Double Medications
-
Underprescribing a Medication
-
Value-Based Pricing Index (VBPI) of Dranitsaris et al for a New Drug to Treat Metastatic Colorectal Carcinoma
-
Impact of Impaired Vision on the Ability of an Older Adult to Take Medications
-
Pillbox Ratio
-
Algorithm of Her et al for Evaluating the Appropriateness of Overriding an Alert for a Nonformulary Medication in a Computerized Prescriber Order Entry (CPOE) System
-
Therapeutic Index (TIX) of Schafer et al for Comparing Intransal Corticosteroids for Management of Allergic Rhinitis
-
Classification of Neville et al for Prescription Errors
-
Pediatric Dosing Errors During Prehospital Emergency Care
-
Recommendations of Farrell et al for Deprescribing Proton Pump Inhibitors (PPIs)
-
Pill Burden
-
Frequency of Medication-Related Preventable Hospital Readmissions Based on the Study of Pellegrin et al
-
Risk Factors of Ruiz et al for Hospital Readmission for an Adverse Drug Reaction (ADR)
-
Risk Factors of Leendertse et al for a Preventable Medication-Related Hospital Admission
-
Conversion Factors of van Leeuwen et al for Vitamin K Antagonist Doses (Acenocoumarol, Phenprocoumon and Warfarin)
-
Risk Scores of Layton et al for Dependence and Aberrant Behaviors for a Patient Starting a Pain Medication
-
Topical Morphine or Opiate Cream or Gel for a Painful Cutaneous Ulcer
-
Therapeutic Errors in Older Adults Identified by Hayes et al
-
Errors in the Dosing of Ocaliva (Obeticholic Acid) in a Patient with Primary Biliary Cholangitis (PBC)
-
Child-Resistant (C-R) Packaging
-
Desiccants and Sorbents
-
Dosing Sustained-Release Donepezil in Koreans with Alzheimer's Disease
-
Decreased Absorption of Orally Administered Drugs Due to Sodium Polystyrene Sulfonate (Kayexalate)
-
Potential Impact of Cholestyramine, Colestipol or Other Bile Acid Binding Resin on Drug Absorption
-
Hypersensitivity Reaction to Milk Protein in Lactose Used As a Drug Excipient
-
PRN (Pro Re Nata, As Needed) Prescription
-
Duke Medication Assist Scale of Jamerson et al (Older Adults Medication Assist Scale)
-
Drug Regimen Unassisted Grading Scale (DRUGS) of Edelberg et al
-
Functional Tasks of Wilbur and Wong for Evaluating the Ability of a Patient to Cope with Medication Packaging
-
Medication Management Ability Assessment (MMAA) of Patterson et al
-
Deprescribing a Benzodiazepine
-
Risk Factors of Gerlach et al for Long-Term Benzodiazepine Use in an Older Adult
-
HEEADSSS Assessment of Jones et al for an Adolescent Receiving Long-Term Anticoagulation Therapy
-
Dose Equivalence of Antiparkinsonian Drugs in Japan
-
Dose Equivalence of Antidepressants in Japan
-
Dose Equivalence of Anxiolytics, Sedatives and Hypnotics in Japan
-
Dose Equivalence of Oral Antipsychotic Drugs in Japan
-
Dose Equivalence of Shorting-Acting Injectable Antipsychotic Agents in Japan Versus Oral Chlorpromazine
-
Dose Equivalence of Oral versus Injectable Formulations of Short-Acting Antipsychotic Agents in Japan
-
Dose Equivalence of Long-Acting Injectable Antipsychotic Agents in Japan
-
Hazards Associated with an Herbal or Alternative Therapy
-
Self-Medication
-
Use of Herbal or Alternative Therapy During Pregnancy
-
Counterfeit Herbal or Alternative Medicine Ingredient
-
Dosing Recommendations of Lalau et al for Metformin in a Patient with Type 2 Diabetes and Stage 3 or 4 Chronic Kidney Disease (CKD)
-
Rebound of Multiple Sclerosis (MS) After Discontinuation of Natalizumab (NTZ)
-
Disposal of Outdated or Unwanted Pharmaceuticals in the Trash
-
Risk Factors for Misunderstanding a Medication Label
-
Complications of Long-Term Benzodiazepine Therapy
-
Deprescribing Medicines for a Patient in Palliative Care or with Limited Life Expectancy
-
Dose Equivalence for Erythropoiesis-Stimulating Agents (Recombinant Erythropoietin, Epoetin Beta, Darbepoetin Alfa)
-
Opioid Risk Tool of Webster and Webster
-
Aberrant Behaviors of Webster and Webster for a Patient Seeking Opioids for Pain
-
Revised Opioid Risk Tool of Cheatle et al
-
Polyherbal Therapy
-
Compounded Topical Pain Creams
-
Rebound Insomnia Following Discontinuation of an Hypnotic Agent
-
Reaction to Sorbitol by a Patient with Hereditary Fructose Intolerance
-
Medication Fall Risk Score of Beasley and Patatanian
-
Self-Medication with Activated Charcoal
-
Chlorine Dioxide (Miracle Mineral Solution, Miracle Mineral Supplement)
-
Causes of Nontherapeutic INR in a Patient Receiving Warfarin for Deep Vein Thrombosis (DVT)
-
Discontinuation of Beta-Blocker Therapy in a Hospitalized Patient with Cirrhosis and Ascites
-
Disposal of an Aerosol Can or Cannister
-
Cholestyramine in Hyperthyroidism
-
Resins for Absorption and Removal of Bile Acids from the Gastrointestinal Tract
-
Predictors of Brant et al for Oversedation of a Hospitalized Patient
-
Maximum Tolerated Dose (Maximal Tolerated Dose, MTD)
-
DIRE Score of Belgrade et al for Outcome of Opioid Therapy of Chronic Noncancer Pain
-
Classification of Von Korff et al for Opioid Therapy for Non-Cancer Pain
-
Questionnaire of Skala et al for Predicting Addiction to Opioid Analgesics
-
Risk Factors of Boscarino et al for Drug Dependency in an Outpatient with Noncancer Pain Treated with Opioids
-
Current Opioid Misuse Measure (COMM) of Butler et al
-
Screener and Opioid Assessment for Patients with Pain (SOAPP)
-
Hypoglycemia Associated with a Dietary Supplement for Male Enhancement
-
Prescribing for a Patient with Decompensated Cirrhosis
-
Risk Factors for Opioid and Benzodiazepine Co-Prescription
-
Scale of Dean and Barber for Scoring the Severity of a Medication Error
-
Prescribing a Proton Pump Inhibitor (PPI) for a Patient with Cirrhosis
-
Nomogram of Lamberink et al for Predicting Seizure Recurrence After Discontinuing of Antiepileptic Drug (AED) Therapy
-
Prognostic Index of the Medical Research Council (MRC) for Seizure Recurrence After Apparent Remission
-
Discontinuation of Diuretic Therapy
-
New Gastrointestinal Binders for Hyperkalemia: Patiromer and Sodium Zirconium Cyclosilicate
-
Colestimide
-
Nitrosodimethylamine (NDMA, Dimethylnitrosamine)
-
Cumulative Steroid Dose
-
Defined Daily Dose (DDD)
-
Dosage Categories of a Beta-Blocking Drug
-
Opioid Risk Tool (ORT) of Webster and Webster for Predicting Drug Misuse in a Patient Receiving Opioids for Chronic Pain
-
Risk Factors of Edlund et al for Opioid Abuse by Veterans With Chronic Non-Cancer Pain (CNCP)
-
Risks Associated with Long-Term Opioid Therapy in an Older Adult
-
Ingestion of Potassium Nitrate (Saltpeter)
-
Medications Errors Associated with Pediatric Chemotherapy
-
Hazards of Veterinary Drugs to Humans
-
Signs That an Animal Owner May Be Abusing the Animal's Medications
-
Findings Suggestive of Controlled Drug Diversion in a Veterinary Practice
-
Castor Oil
-
Criteria for an Over-the-Counter (OTC, Nonprescription) Drug
-
Reasons Why a Drug May Be of Poor Quality
-
Pediatrics Omission of Prescriptions and Inappropriate Prescriptions (POPI): Pulmonary and Gastrointestinal Tract
-
Pediatrics Omission of Prescriptions and Inappropriate Prescriptions (POPI): Skin Disorders and Insects
-
Pediatrics Omission of Prescriptions and Inappropriate Prescriptions (POPI): Neurologic Drugs
-
Pediatrics Omission of Prescriptions and Inappropriate Prescriptions (POPI): Miscellaneous Drugs
-
Traits of People Who Experiment with Alternative Therapies
-
Wearing Off
-
Risk Factors of Raja et al for Wearing-Off in Parkinson's Disease
-
Distant Spread of Botulinum Toxin
-
Dose Units for Botulinum Toxin
-
Psychotropic (Psychoactive) Drugs
-
Classes of Antiarrhythmic Drugs
-
Medicines Optimisation Assessment Tool (MOAT) of Geeson et al for Preventing Medication-Related Problems
-
Inappropriate Combination Therapy for Arterial Hypertension
-
Appropriateness Rating Scale for a Therapy
-
Polypharmacy and Drug Burden in HIV-Positive Adults
-
Risk Factors of Rasool et al for Medication Errors for a Patient with Chronic Disorders
-
Risk Factors of Weant et al for Medication Errors in the Emergency Department
-
Safety Checks of Weant et al for Preventing Medication Errors
-
Medication Errors of Peth: Prescription Errors
-
Medication Errors of Peth: Ways to Reduce Transcription Errors
-
Medication Errors of Peth: Dosing and Dispensing Safety Checks
-
Medication Errors of Peth: Administration Errors
-
Medication Errors of Peth: Monitoring Errors
-
Risk Factors of Ramadanov et al for Medication Errors in Prehospital Care
-
Risk Factors of Walsh et al for Medication Errors Affecting Pediatric Patients at Home
-
Risk Factors of Martins et al for Inadequate Medicine Home Storage
-
Causes of Drug Wastage
-
Hazards Associated with Aerosols of Chemotherapy Fluids
-
Organoleptic Evaluation
-
Tapering a Drug Dose
-
Pill Aversion
-
Drug Sparing (Steroid-Sparing, Other)
-
Polypharmacy and Other Risk Factors for 30-Day Hospital Readmission in a Geriatric Medical Patient
-
Milligram Morphine Equivalent (MME) in Chronic Pain Management
-
Indications for Referring a Chronic Pain Patient to a Pain Specialist
-
Indications for Discontinuation of Opioid Therapy in a Chronic Pain Patient
-
Red Flags for Possible Opioid Misuse in a Chronic Pain Patient
-
MidMichigan Opioid Risk Assessment (MORA) for Risk of Adverse Events from Opioid Therapy
-
Opioid Therapy in Patients with Comorbid Conditions
-
Indications to Prescribe Naloxone for a Chronic Pain Patient Treated with an Opioid
-
Instructions for Patients About Storage of Opioids in the Home and Their Disposal
-
Conversion of a Chronic Pain Patient from an Opioid to Methadone
-
Conversion of a Chronic Pain Patient from an Opioid to Fentanyl Patch
-
Adverse Effects of Opiate Therapy in a Pain Patient
-
Transdermal Buprenorphine for a Patient with Chronic Pain
-
Buccal Buprenorphine for a Patient with Chronic Pain
-
Violations of a Patient and Clinician Agreement for Opioid Therapy
-
Patient and Drug Agreement with Expectations Prior to Starting Opioid Therapy for Chronic Pain
-
Operational Tasks When Starting a Chronic Pain Patient on Opioid Therapy
-
Sublingual Buprenorphine for a Patient with Chronic Pain: Switching from a Short-Acting Opioid
-
Sublingual Buprenorphine for a Patient with Chronic Pain: Switching from an Intermediate-Acting Opioid
-
Sublingual Buprenorphine for a Patient with Chronic Pain: Switching from an Long-Acting Opioid
-
Discontinuation of Opioid Therapy in a Chronic Pain Patient
-
Checklist for Follow-Up Visits by a Chronic Pain Patient
-
Monitoring the Prescription Drug Monitoring Program (PDMP) Database in a Chronic Pain Patient
-
Assuming Care of a Chronic Pain Patient Already Receiving Opioids
-
Prediction of Methadone Serum Trough Concentration from the Daily Dose
-
Individualized Treatment Plan for a Chronic Pain Patient
-
Managing the Prescription for Opioids
-
Initial Assessment of a Chronic Pain Patient
-
Selecting Opioid Therapy for a Chronic Pain Patient
-
Differential Diagnosis of a Failure in Pain Control with an Opioid
-
Risk Factors of Eslami et al for Medication Errors in a Neonatal Intensive Care Unit (NICU)
-
Medication Errors of Kassem et al Related to Prescriptions for Outpatient Pediatric Patients
-
Contamination of Environmental Surfaces with Antineoplastic Drugs
-
Polypharmacy and Emergency Readmission to the Hospital After Critical Illness
-
MERIS (Medication Risk Score) of Saedder et a for Evaluating the Risk of a Drug-Related Problem
-
Association of Polypharmacy and Malnutrition in Older Adults
-
Model of Tang et al for Predicting Polypharmacy in a Community-Dwelling Elderly Patient
-
Criteria of Phadke for Appropriateness of Prescribing
-
NORGEP Criteria for Potentially Inappropriate Prescribing in the Elderly
-
Cancer Opioid Risk Score
-
Toxic Cough Syrup
-
Medication Reconciliation Risk Stratification Tool of Chu et al: Score 1
-
Medication Reconciliation Risk Stratification Tool of Chu et al: Score 2
-
Z-Drug Hypnotics
-
Guidance of Gradalski for Deprescribing and Prescribing for a Patient Starting Palliative Care
-
Prescribing Cascade
-
Types of Failures in the Use of a High-Risk Medication Associated with Preventable Hospital Admissions
-
Criteria of Dreischulte and Guthrie for High-Risk Prescribing
-
Algorithm of Lee et al for Deprescribing for a Patient with Rheumatoid Arthritis
-
Barriers for Deprescribing Medications
-
Indications for Opioid Rotation
-
Drug Interactions Associated with St. John's Wort
-
Causes of Medication Errors for the Home Care Patient
-
Systemic Absorption from a Topical Drug
-
Care and Use of a Spacer Device
-
Counterfeit Sildenafil and Other Phosphodiesterase Type 5 Inhibitors
-
Deprescribing Psychotropic Drugs for a Patient with Intellectual Disability
-
Risk Factors of Schonenberger and Meyer-Massetti for Medication-Related 30-Day Readmission for an Adult
-
Emergency Medicine Pharmacy Intensity Score Tool (EMPIST)
-
Adverse Effects Associated with Tea Tree Oil
-
Predictors of Tsukiyama et al for Early Discontinuation of Anamorelin for a Patient with Cancer-Associated Cachexia
-
Predictors of Brandt et al for Relapse of Psychosis Following Discontinuation of Paliperidone
-
Clinical Findings Following Clozapine Discontinuation
-
Nomograms of Ferreira-Atuesta et al for Withdrawal of Antiseizure Medications After Epilepsy Surgery: Nomogram A for Seizure Freedom
-
Nomograms of Ferreira-Atuesta et al for Withdrawal of Antiseizure Medications After Epilepsy Surgery: Nomogram A for Complete Seizure Freedom
-
Environmental Contamination with Pharmaceuticals
-
Potential Problems When Delivering a Medication By a Feeding Tube